tomeko

Congenital dyserythropoietic anemia, type II

Just diagnosed with Congenital dyserythropoietic anemia, type II?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Congenital dyserythropoietic anemia, type II, look for clinical trials, and connect with others living with it — all in one place.

Open the full Congenital dyserythropoietic anemia, type II hub →

Overview

Congenital dyserythropoietic anemia, type II is a rare condition. Also known as CDA II, CDA type 2, CDA type II, Congenital dyserythropoietic anemia type 2, Hereditary erythroblastic multinuclearity with a positive acidified-serum test (hempas), SEC23B-CDG. Tomeko brings together the specialists, research, clinical trials, treatments and community for Congenital dyserythropoietic anemia, type II so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:98873 · OMIM 224100 · ICD-10 D64.4 · GARD 0002001

Find care for Congenital dyserythropoietic anemia, type II

Authoritative references for Congenital dyserythropoietic anemia, type II

Common questions

I was just diagnosed with Congenital dyserythropoietic anemia, type II — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Congenital dyserythropoietic anemia, type II, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Congenital dyserythropoietic anemia, type II?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Congenital dyserythropoietic anemia, type II, filtered to your area.

Are there clinical trials for Congenital dyserythropoietic anemia, type II?

Tomeko shows live, recruiting studies for Congenital dyserythropoietic anemia, type II from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com